INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-683 Cr | ₹-327 Cr | ₹-893 Cr | ₹-160 Cr | ₹-24 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDEGENE ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-683 Cr |
| Mar2024 | ₹-327 Cr |
| Mar2023 | ₹-893 Cr |
| Mar2022 | ₹-160 Cr |
| Mar2021 | ₹-24 Cr |
How is Cash Flow from Investing Activities of INDEGENE Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-683 Cr | Negative | |
| Mar2024 | ₹-327 Cr | Negative | |
| Mar2023 | ₹-893 Cr | Negative | |
| Mar2022 | ₹-160 Cr | Negative | |
| Mar2021 | ₹-24 Cr | - | |
Compare Cash Flow from Investing Activities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,087.6 Cr | 3.4% | -4.7% | -17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 3.4% |
-4.7% |
-17.4% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses